THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT DATED AS OF NOVEMBER 7, 2023 BY AND AMONG AMNEAL GROUP (AS DEFINED HEREIN), AMNEAL PHARMACEUTICALS LLC, AMNEAL INTERMEDIATE INC. AND AMNEAL PHARMACEUTICALS, INC.Stockholders Agreement • November 8th, 2023 • Amneal Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 8th, 2023 Company Industry JurisdictionTHIS THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (as may be further amended from time to time in accordance with the terms hereof, this “Agreement”), is entered into as of November 7, 2023, by and among Amneal Pharmaceuticals, Inc., a Delaware corporation (formerly known as Amneal NewCo Inc.) (the “Company”), Amneal Intermediate Inc. (formerly known as Amneal Pharmaceuticals, Inc. and Atlas Holdings, Inc.), a Delaware corporation (“Old PubCo”), Amneal Pharmaceuticals LLC, a Delaware limited liability company (“Opco”) and each other Person set forth on the signature pages hereto (collectively, the “Amneal Group” and individually each, an “Amneal Group Member”).
SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT DATED AS OF DECEMBER 16, 2017 BY AND AMONG AMNEAL GROUP (AS DEFINED HEREIN) AND ATLAS HOLDINGS, INC.Stockholders Agreement • April 13th, 2018 • Atlas Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 13th, 2018 Company Industry JurisdictionSECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT, dated December 16, 2017 (this “Agreement”), by and among Amneal Pharmaceuticals Holding Company, LLC, a Delaware limited liability company, AP Class D Member, LLC, a Delaware limited liability company, AP Class E Member, LLC, a Delaware limited liability company, AH PPU Management, LLC, a Delaware limited liability company, and Atlas Holdings, Inc., a Delaware corporation (the “Company”).